Indication
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a progressive, fatal neurodegenerative disorder characterized by the selective degeneration and death of upper motor neurons in the cerebral cortex and lower motor neurons in the brainstem and spinal cord. Read more about Amyotrophic lateral sclerosis
23 drugs 18 manufacturers
Drugs that treat it
Common Amyotrophic lateral sclerosis therapies.
RILUZOLE
RILUZOLE
RILUZOLE
RILUZOLE
RILUZOLE
RILUZOLE
RADICAVA (edaravone)
TIGLUTIK (riluzole)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAmyotrophic lateral sclerosis is a progressive, fatal neurodegenerative disorder characterized by the selective degeneration and death of upper motor neurons in the cerebral cortex and lower motor neurons in the brainstem and spinal cord.
Primarily affecting adults—most commonly presenting between 55 and 75 years of age—it leads to the interruption of neural signaling to voluntary muscles.
Clinically, the disease manifests with a combination of lower motor neuron features, such as progressive muscle weakness, wasting, cramps, and fasciculations, along with upper motor neuron signs like spasticity and hyperreflexia.
As the pathology spreads through spinal and bulbar motor circuits, patients experience worsening limb paralysis, dysarthria, and dysphagia, ultimately resulting in respiratory failure.
- nih.gov
Amyotrophic lateral sclerosis is a progressive, fatal neurodegenerative disorder characterized by the selective degeneration and death of upper motor neurons in the cerebral cortex and lower motor neurons in the brainstem and spinal cord Clinically, the disease manifests with a combination of lower motor neuron features, such as progressive muscle weakness, wasting, cramps, and fasciculations, along with upper motor neuron signs like spasticity and hyperreflexia As the pathology spreads through ...
- nih.gov
Amyotrophic lateral sclerosis is a progressive, fatal neurodegenerative disorder characterized by the selective degeneration and death of upper motor neurons in the cerebral cortex and lower motor neurons in the brainstem and spinal cord
- nih.gov
Primarily affecting adults—most commonly presenting between 55 and 75 years of age—it leads to the interruption of neural signaling to voluntary muscles Clinically, the disease manifests with a combination of lower motor neuron features, such as progressive muscle weakness, wasting, cramps, and fasciculations, along with upper motor neuron signs like spasticity and hyperreflexia As the pathology spreads through spinal and bulbar motor circuits, patients experience worsening limb paralysis, dysar...
- medlineplus.gov
Primarily affecting adults—most commonly presenting between 55 and 75 years of age—it leads to the interruption of neural signaling to voluntary muscles
Personalize your experience
Follow Amyotrophic lateral sclerosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.